Jul
31
2024
FDA Approves Erzofri for the Treatment of Schizophrenia and Schizoaffective Disorder – Psychiatric Times
FDA Approves Erzofri for the Treatment of Schizophrenia and Schizoaffective Disorder Psychiatric Times